---
title: "瑞穗证券发布了关于 LeonaBio（LONA）的正面报告"
description: "瑞穗证券分析师 Graig Suvannavejh 将 LeonaBio (LONA) 的评级上调至买入，目标价为 10.00 美元。Suvannavejh 专注于医疗保健领域，推荐股票的平均回报率为 20.3%，成功率为 50.00%。此外，TipRanks 对 LeonaBio 进行了覆盖，给予买入评级，目标价为 5.00 美元"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276278570.md"
published_at: "2026-02-18T21:55:33.000Z"
---

# 瑞穗证券发布了关于 LeonaBio（LONA）的正面报告

> 瑞穗证券分析师 Graig Suvannavejh 将 LeonaBio (LONA) 的评级上调至买入，目标价为 10.00 美元。Suvannavejh 专注于医疗保健领域，推荐股票的平均回报率为 20.3%，成功率为 50.00%。此外，TipRanks 对 LeonaBio 进行了覆盖，给予买入评级，目标价为 5.00 美元

瑞穗证券分析师 Graig Suvannavejh 今天将 LeonaBio 评级上调至买入，并设定目标价为 10.00 美元。

### 总统日促销 - 70% 折扣

-   解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策
-   通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力

Suvannavejh 覆盖医疗保健行业，关注的股票包括 EyePoint Pharmaceuticals、Axsome Therapeutics 和 Terns Pharmaceuticals。根据 TipRanks 的数据，Suvannavejh 的平均回报率为 20.3%，推荐股票的成功率为 50.00%。

在 2 月 4 日发布的一份报告中，TipRanks – Google 也对该股票进行了覆盖，并给予买入评级，目标价为 5.00 美元。

### Related Stocks

- [LONA.US - LeonaBio](https://longbridge.com/zh-CN/quote/LONA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Progyny (PGNY) Valuation In Focus After Recent Share Price Weakness | Progyny (PGNY) has faced significant share price declines, with a recent drop of 20.49% to $17.69, leading investors to  | [Link](https://longbridge.com/zh-CN/news/277364504.md) |
| Is Piper Sandler (PIPR) Quietly Recasting Its Healthcare Brand Around High-Margin Advisory Niches? | Piper Sandler Companies has expanded its healthcare investment banking by appointing Jason Arnold and Aamer Naseer to ke | [Link](https://longbridge.com/zh-CN/news/277345069.md) |
| Huron Consulting is Positioned to Capitalize on Double-Digit Growth Across Core Verticals, Wedbush Says | Huron Consulting (HURN) is poised for double-digit growth in core sectors, driven by increased client demand amid market | [Link](https://longbridge.com/zh-CN/news/276916978.md) |
| Roth MKM Sticks to Their Buy Rating for HEALWELL AI (AIDX) | Roth MKM analyst Kyle Bauser has maintained a Buy rating for HEALWELL AI (AIDX) with a price target of C$2.50. Bauser, w | [Link](https://longbridge.com/zh-CN/news/277098766.md) |
| Pharming Group Touts 2025 Sales Surge, Joenja Expansion Plans at Oppenheimer Healthcare Conference | Pharming Group (NASDAQ:PHAR) executives presented at Oppenheimer’s 36th Annual Healthcare Conference, highlighting a pro | [Link](https://longbridge.com/zh-CN/news/277357170.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。